Jong-Ryoo Choi, Jong-Kuk Park, Sung-Kyun Ko. "Clinical candidate JNC-1043, importin ß inhibitor (first in class), to target incurable cancers, TNBC, and colon cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e15096